Version 2.78

Term Description

Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at this facility or the reason they were not given. Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to tumor cells.

Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of immunotherapeutic agents as part of the first course of therapy.. NAACCR Data Standards and Data Dictionary Version 11
Source: Regenstrief LOINC

Fully-Specified Name

Component
Biological response modifier Rx
Property
Type
Time
Pt
System
Cancer.XXX
Scale
Nom
Method

Additional Names

Short Name
Biological response modifier Rx Cancer

Normative Answer List: LL98-5

Answer Code Score Answer ID
NoneCopyright http://snomed.info/sct ID:260413007 None (qualifier value)

Screen time

 0 LA137-2
Immunotherapy was not administered because the patient died prior to planned or recommended therapy 85 LA3936-7
Immunotherapy was recommended, but it is unknown if it was administered 88 LA3947-4
Immunotherapy was recommended by the physician, but was refused by patient/family member/guardian 87 LA3948-2
Immunotherapy not recommended/administered due to patient risks (comorbid conditions, advanced age) 82 LA3952-4
Immunotherapy administered as first-course therapy 01 LA3957-3
Immunotherapy was recommended by the physician, but was not administered; no reason was stated 86 LA3964-9
Combination of 1 and any 2, 3, 4, or 5 6 LA4212-2
Biological response modifier (BRM) 1 LA4272-6
Bone marrow transplant, NOS 4 LA4278-3
Bone marrow transplant?allogeneic 3 LA4279-1
Bone marrow transplant?autologous 2 LA4280-9
Biological response modifier recommended, unknown if adminis 8 LA4282-5
Unknown if BRM administered 9 LA4400-3
Unknown if immunotherapy recommended/administered (not in pat. record); death certificate-only cases 99 LA4414-4
Stem Cell Transplant 5 LA4478-9
UnknownCopyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) 00 LA4489-6
Patient or patient's guardian refused 7 LA4640-4

Basic Attributes

Class
TUMRRGT
Type
Clinical
First Released
Version 1.0m
Last Updated
Version 2.29

Member of these Panels

LOINC Long Common Name
49083-9 North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
59852-4 North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

Language Variants Get Info

Tag Language Translation
es-AR Spanish (Argentina) tratamiento modificador de la respuesta biológica:tipo:punto en el tiempo:cáncer.XXX:Nominal:
es-MX Spanish (Mexico) Modificador de respuesta biológica Rx:Tipo:Punto temporal:Cancer.XXX:Nominal:
it-IT Italian (Italy) Terapia modificatore risposta biologica:Tipo:Pt:Cancro.XXX:Nom:
Synonyms: Cancro XXX Neoplasia maligna Punto nel tempo (episodio) Registro tumori Trattamento modificatore della risposta biologica
ru-RU Russian (Russian Federation) Биологический ответ модификатор Rx:Тип:ТчкВрм:Рак.XXX:Ном:
Synonyms: Номинальный;Именной Точка во времени;Момент
zh-CN Chinese (China) 生物反应调节剂治疗方案:类型:时间点:癌.XXX:名义型:
Synonyms: NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记（NAACCR）;肿瘤登记（癌症登记中心北美协会）;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 不明癌;不明癌症;未作说明的癌;未作说明的癌症;癌.不明;癌.未作说明的;癌症.XXX;癌症.不明;癌症.未作说明的;此处未作说明的癌 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 型 时刻;随机;随意;瞬间 生物反应调节剂处方 癌

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=21948-5